Yahoo · Sep 10, 2026
ELTP Downgraded to Neutral on Pricing Pressure & Limited Visibility
Elite Pharmaceuticals' downgrade to Neutral cites pricing pressure, weaker revenue and margins, and limited visibility into new-product contributions.
EL
OTC · ELTP
Elite Pharmaceuticals, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$0.23
Up+$0.00 (+1.32%)
Updated Oct 3, 2026, 10:48 AM
SID Score
4.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 554.52M
- P/E ratio
- 39.95
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 676.13K
- Avg. volume
- 816.74K
Price performance · ELTP
ELTP price history
1M range · 0 trading sessions · Daily adjusted prices
ELTP does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest ELTP news
The latest Smart Investors Daily articles mentioning ELTP.
Stock researchCompany · Overview
Company
Market Activity
Research & News
ELTP research
Overview
Company profile and research snapshot.
Company profile
ELITE PHARMS INC
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
Yahoo · Aug 25, 2026
ELTP vs. DERM: Which Specialty Pharmaceutical Stock Is the Better Buy?
Elite Pharmaceuticals and Journey Medical follow different growth paths, but which looks more compelling now? Let's dive in.
Yahoo · Aug 19, 2026
Elite Pharmaceuticals Stock Plunges Post Q1 Earnings, Revenues Fall Y/Y
ELTP's first-quarter fiscal 2027 revenues decline as generic competition and lower pricing offset higher volumes, while pipeline development remains a growth focus.
SeekingAlpha · Aug 14, 2026
Elite Pharmaceuticals, Inc. (ELTP) Q1 2027 Earnings Call Transcript
Elite Pharmaceuticals, Inc. (ELTP) Q1 2027 Earnings Call August 14, 2026 11:30 AM EDTCompany ParticipantsNasrat Hakim - Chairman, CEO & PresidentCarter...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
